Concepedia
Statistics
Publications
34
Citations
2.3K
H-Index
20
Active since
2010
Affiliations
GlaxoSmithKline (Belgium)(Current)
GlaxoSmithKline (India)
GlaxoSmithKline (United Kingdom)
University of Cape Town
South African Medical Research Council
Olivier Van Der Meeren is an author at GlaxoSmithKline (Belgium) specializing in vaccinology, immunization, and immunology.
Publications per year
2010–2021
Final Analysis of a Trial of M72/AS01 <sub>E</sub> Vaccine to Prevent Tuberculosis
Dereck Tait, Mark Hatherill, Olivier Van Der Meeren et al. · New England Journal of Medicine · 2019 · 595 citations · Full text
Veterinary Medicine, Immunology, Infectious Diseases +17
Phase 2b Controlled Trial of M72/AS01 <sub>E</sub> Vaccine to Prevent Tuberculosis
Olivier Van Der Meeren, Mark Hatherill, Videlis Nduba et al. · New England Journal of Medicine · 2018 · 412 citations · Full text
Medicine, Infectious Diseases, Preventive Medicine +17
Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120–MF59 in Adults
Glenda Gray, Linda‐Gail Bekker, Fatima Laher et al. · New England Journal of Medicine · 2021 · 231 citations · Full text
Decennial Administration of a Reduced Antigen Content Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine in Young Adults
Jussi Mertsola, Olivier Van Der Meeren, Qiushui He et al. · Clinical Infectious Diseases · 2010 · 96 citations · Full text
Medicine, Immunology, Pediatrics +17
Effect of a Prepregnancy Pertussis Booster Dose on Maternal Antibody Titers in Young Infants
Elke Leuridan, Niel Hens, Natasja Peeters et al. · The Pediatric Infectious Disease Journal · 2011 · 95 citations
Medicine, Immunology, Maternal Health +17
1–5 of 34